CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Secretaria da Saúde (São Paulo - Estado). Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Instituto do Coração Professor Euryclides de Jesus Zerbini (INCOR) (Institutional affiliation for the last research proposal) Birthplace: Brazil
Graduated in Medicine in 1989. Residency in Internal Medicine at Hospital das Clínicas e Cardiology at Instituto do Coração (InCor) of FMUSP (1990-1992). Doctorate in Cardiology from the Faculty of Medicine of the University of São Paulo (1999) and Full Professor in Cardiology from the Faculty of Medicine of the University of São Paulo (2005). Associate Professor (MS-3) at the Faculty of Medicine of USP, Department of Cardiopneumology. He is currently Director of the Clinical Unit of Cardiac Transplantation at Instituto do Coração (InCor) at Hospital das Clínicas, Faculty of Medicine of USP and Professor of Internal Medicine at Faculdade Israelita de Ciencias da Saúde Albert Einstein. He has experience in the field of Medicine, with an emphasis on Cardiology, working mainly on the following topics: heart failure, cardiomyopathies, myocarditis, heart transplantation, Chagas disease, graft vascular disease after transplantation, rejection and immunosuppression. He was Editor-in-Chief of the Brazilian Archives of Cardiology in 2008-2009, President of the Department of Heart Failure of the Brazilian Society of Cardiology (SBC) in 2010-2011 and Research Director of the Brazilian Society of Cardiology (SBC) in 2012-2013 / 2018 -2019. He is currently Scientific Director of the Brazilian Society of Cardiology (2020-2021) and member of the Technical Chambers of the Regional Council of Medicine-SP, State Health Department (Heart Transplantation) and of the National Transplantation System (SNT). Appointed member of the Superior Council of CAPES, for the triennium 2021-2023. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Despite advances in treatment of heart failure (HF), mortality remains high in these patients and many have exercise intolerance and dyspnea. Small studies and meta-analysis suggested that physical exercise promotes improvement of symptoms and reduces mortality. However, more recently, a randomized clinical trial found no benefit on survival or hospitalization with physical training in pa…
Cirrhotic cardiomyopathy is defined as a chronic cardiac dysfunction in patients with cirrhosis, characterized by inadequate myocardial contractile response to stress and / or diastolic dysfunction with electrophysiological abnormalities in the absence of primary cardiac disease. It is suspected that cardiac dysfunction in cirrhotic contribute to the genesis of complications in liver di…
(Only some records are available in English at this moment)
Eosinophilic myocarditis (EM) is a rare myocardial disorder in autopsy studies, however with a high incidence among patients in the waiting list for a heart transplant, probably due to the prolonged use of dobutamine. EM can worsen the state of the patient with CHF, because they have already low cardiac reserve. Furthermore, its variable clinical manifestation and non-specific heart signs…
Infection by cytomegalovirus (HCMV) is the most prevalent correlated with the first year after heart transplantation in adults. Despite the promising advances in reducing post - surgery complications, this infection is responsible for increasing the risk of chronic rejection, vascular graft disease and the mortality rate. However, in our institution is scarce literature on the relationshi…
Background: cytomegalovirus (CMV) infection is one of the most frequent complications in the first year after adult heart transplantation. CMV infection is related to chronic rejection, cardiac allograft vasculopathy and high mortality. CMV infection occurs as a latent virus reactivation or as a primary infection in patients with negative serology to CMV receiving an organ from a CMV posi…
| 6 / 5 | Completed research grants |
| 3 / 3 | Completed scholarships in Brazil |
| 9 / 8 | All research grants and scholarships |
| Associated processes | |